Titre : Polykystose rénale autosomique dominante

Polykystose rénale autosomique dominante : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multivariate Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Polykystose rénale autosomique dominante : Questions médicales les plus fréquentes", "headline": "Polykystose rénale autosomique dominante : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Polykystose rénale autosomique dominante : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-01", "dateModified": "2025-03-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Polykystose rénale autosomique dominante" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Polykystoses rénales", "url": "https://questionsmedicales.fr/mesh/D007690", "about": { "@type": "MedicalCondition", "name": "Polykystoses rénales", "code": { "@type": "MedicalCode", "code": "D007690", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C16.320.184.625" } } }, "about": { "@type": "MedicalCondition", "name": "Polykystose rénale autosomique dominante", "alternateName": "Polycystic Kidney, Autosomal Dominant", "code": { "@type": "MedicalCode", "code": "D016891", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Vicente E Torres", "url": "https://questionsmedicales.fr/author/Vicente%20E%20Torres", "affiliation": { "@type": "Organization", "name": "Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA; Mayo Clinic Robert M. and Billie Kelley Pirnie Translational Polycystic Kidney Disease Center, Rochester, Minnesota, USA. Electronic address: Torres.vicente@mayo.edu." } }, { "@type": "Person", "name": "Peter C Harris", "url": "https://questionsmedicales.fr/author/Peter%20C%20Harris", "affiliation": { "@type": "Organization", "name": "Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN." } }, { "@type": "Person", "name": "Sarah R Senum", "url": "https://questionsmedicales.fr/author/Sarah%20R%20Senum", "affiliation": { "@type": "Organization", "name": "Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Ronald D Perrone", "url": "https://questionsmedicales.fr/author/Ronald%20D%20Perrone", "affiliation": { "@type": "Organization", "name": "Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA, USA. Electronic address: rperrone@tuftsmedicalcenter.org." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Multilayer network analysis in patients with juvenile myoclonic epilepsy.", "datePublished": "2024-06-07", "url": "https://questionsmedicales.fr/article/38847850", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00234-024-03390-3" } }, { "@type": "ScholarlyArticle", "name": "Post-traumatic Stress Disorder in Veterans: A Concept Analysis.", "datePublished": "2024-06-07", "url": "https://questionsmedicales.fr/article/38920817", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/bs14060485" } }, { "@type": "ScholarlyArticle", "name": "Comparative Analysis of Surgical Techniques for Wisdom Tooth Extraction.", "datePublished": "2024-06-07", "url": "https://questionsmedicales.fr/article/39346299", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4103/jpbs.jpbs_260_24" } }, { "@type": "ScholarlyArticle", "name": "Bibliometric analysis on physical ergonomics: A visual mapping approach.", "datePublished": "2024-06-04", "url": "https://questionsmedicales.fr/article/38848152", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3233/WOR-230367" } }, { "@type": "ScholarlyArticle", "name": "Identification and functional analysis of a deduced geraniol synthase from", "datePublished": "2024-06-02", "url": "https://questionsmedicales.fr/article/38974359", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12298-024-01463-4" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Malformations et maladies congénitales, héréditaires et néonatales", "item": "https://questionsmedicales.fr/mesh/D009358" }, { "@type": "ListItem", "position": 3, "name": "Maladies génétiques congénitales", "item": "https://questionsmedicales.fr/mesh/D030342" }, { "@type": "ListItem", "position": 4, "name": "Ciliopathies", "item": "https://questionsmedicales.fr/mesh/D000072661" }, { "@type": "ListItem", "position": 5, "name": "Polykystoses rénales", "item": "https://questionsmedicales.fr/mesh/D007690" }, { "@type": "ListItem", "position": 6, "name": "Polykystose rénale autosomique dominante", "item": "https://questionsmedicales.fr/mesh/D016891" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Polykystose rénale autosomique dominante - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Polykystose rénale autosomique dominante", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Polykystose rénale autosomique dominante", "description": "Comment diagnostiquer la polykystose rénale autosomique dominante ?\nQuels tests génétiques sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent cette maladie ?\nÀ quel âge se manifeste généralement la maladie ?\nL'échographie est-elle suffisante pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D016891?mesh_terms=Multivariate+Analysis&page=998#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Polykystose rénale autosomique dominante", "description": "Quels sont les symptômes courants de la maladie ?\nLa polykystose rénale cause-t-elle des problèmes urinaires ?\nPeut-on avoir des symptômes sans kystes visibles ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLa fatigue est-elle un symptôme associé ?", "url": "https://questionsmedicales.fr/mesh/D016891?mesh_terms=Multivariate+Analysis&page=998#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Polykystose rénale autosomique dominante", "description": "Peut-on prévenir la polykystose rénale autosomique dominante ?\nComment surveiller la maladie chez les membres de la famille ?\nL'alimentation peut-elle influencer la maladie ?\nLe contrôle de la pression artérielle est-il important ?\nLes examens réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D016891?mesh_terms=Multivariate+Analysis&page=998#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Polykystose rénale autosomique dominante", "description": "Quels traitements sont disponibles pour cette maladie ?\nLes médicaments peuvent-ils ralentir la progression ?\nLa dialyse est-elle nécessaire pour tous les patients ?\nY a-t-il des traitements expérimentaux disponibles ?\nComment gérer les douleurs associées à la maladie ?", "url": "https://questionsmedicales.fr/mesh/D016891?mesh_terms=Multivariate+Analysis&page=998#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Polykystose rénale autosomique dominante", "description": "Quelles sont les complications possibles de la maladie ?\nLa polykystose rénale augmente-t-elle le risque de maladies cardiovasculaires ?\nLes kystes peuvent-ils se développer dans d'autres organes ?\nComment l'insuffisance rénale affecte-t-elle la qualité de vie ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D016891?mesh_terms=Multivariate+Analysis&page=998#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Polykystose rénale autosomique dominante", "description": "Quels sont les facteurs de risque de la polykystose rénale ?\nL'âge influence-t-il le risque de développer la maladie ?\nLes hommes sont-ils plus à risque que les femmes ?\nLes personnes ayant des antécédents de maladies rénales sont-elles à risque ?\nLe mode de vie influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D016891?mesh_terms=Multivariate+Analysis&page=998#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la polykystose rénale autosomique dominante ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'imagerie, comme l'échographie ou l'IRM, et l'historique familial." } }, { "@type": "Question", "name": "Quels tests génétiques sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent identifier des mutations dans les gènes PKD1 ou PKD2." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent cette maladie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent hypertension, douleurs abdominales et hématurie." } }, { "@type": "Question", "name": "À quel âge se manifeste généralement la maladie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes apparaissent souvent entre 30 et 40 ans, mais peuvent survenir plus tôt." } }, { "@type": "Question", "name": "L'échographie est-elle suffisante pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'échographie est souvent suffisante pour visualiser les kystes rénaux." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la maladie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs lombaires, hypertension, et infections urinaires fréquentes." } }, { "@type": "Question", "name": "La polykystose rénale cause-t-elle des problèmes urinaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des infections urinaires et des calculs rénaux." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans kystes visibles ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent ne pas avoir de kystes visibles mais présenter des symptômes." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme associé ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue peut être un symptôme en raison de l'insuffisance rénale progressive." } }, { "@type": "Question", "name": "Peut-on prévenir la polykystose rénale autosomique dominante ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La maladie étant génétique, il n'existe pas de prévention, mais un suivi régulier est conseillé." } }, { "@type": "Question", "name": "Comment surveiller la maladie chez les membres de la famille ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des échographies régulières et des consultations médicales sont recommandées pour les membres à risque." } }, { "@type": "Question", "name": "L'alimentation peut-elle influencer la maladie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et une bonne hydratation peuvent aider à maintenir la santé rénale." } }, { "@type": "Question", "name": "Le contrôle de la pression artérielle est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir une pression artérielle normale est crucial pour ralentir la progression de la maladie." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers permettent de détecter précocement des complications potentielles." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour cette maladie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut la gestion de l'hypertension et, dans les cas avancés, la dialyse ou la transplantation." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils ralentir la progression ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les inhibiteurs de l'angiotensine peuvent aider à contrôler la pression artérielle." } }, { "@type": "Question", "name": "La dialyse est-elle nécessaire pour tous les patients ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Non, la dialyse est nécessaire uniquement lorsque la fonction rénale est gravement altérée." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux disponibles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements expérimentaux, comme les médicaments ciblant la croissance des kystes, sont en cours d'étude." } }, { "@type": "Question", "name": "Comment gérer les douleurs associées à la maladie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des analgésiques et des traitements non médicamenteux peuvent aider à gérer la douleur." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la maladie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance rénale, les infections urinaires et les kystes hépatiques." } }, { "@type": "Question", "name": "La polykystose rénale augmente-t-elle le risque de maladies cardiovasculaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients ont un risque accru de maladies cardiovasculaires en raison de l'hypertension." } }, { "@type": "Question", "name": "Les kystes peuvent-ils se développer dans d'autres organes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des kystes peuvent également se former dans le foie, le pancréas et d'autres organes." } }, { "@type": "Question", "name": "Comment l'insuffisance rénale affecte-t-elle la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "L'insuffisance rénale peut entraîner fatigue, limitations physiques et besoin de dialyse, affectant la qualité de vie." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un suivi médical régulier et un bon contrôle de la pression artérielle." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la polykystose rénale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de la maladie sont le principal facteur de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de développer la maladie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout après 30 ans." } }, { "@type": "Question", "name": "Les hommes sont-ils plus à risque que les femmes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Non, la polykystose rénale touche les hommes et les femmes de manière égale." } }, { "@type": "Question", "name": "Les personnes ayant des antécédents de maladies rénales sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents de maladies rénales peuvent augmenter le risque de complications." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut réduire le risque de complications, mais pas le risque de la maladie elle-même." } } ] } ] }

Sources (10000 au total)

Multilayer network analysis in patients with juvenile myoclonic epilepsy.

We conducted a multilayer network analysis in patients with juvenile myoclonic epilepsy (JME) and healthy controls, to investigate the gray matter layer using a morphometric similarity network and ana... We enrolled 42 patients with newly diagnosed JME and 53 healthy controls. Brain magnetic resonance imaging (MRI) using a three-tesla MRI scanner, including T1-weighted imaging and diffusion tensor ima... There were significant differences in network at the global level in the multilayer network analysis between the groups. The average multiplex participation of patients with JME was lower than that of... We demonstrated differences in network at the global and nodal levels in the multilayer network analysis between patients with JME and healthy controls. These features may be associated with the patho...

Comparative Analysis of Surgical Techniques for Wisdom Tooth Extraction.

Wisdom tooth extraction often requires various surgical techniques due to differences in tooth position, root morphology, and patient characteristics. This research aims to compare traditional surgica... Patients requiring wisdom tooth extraction were randomly assigned to one of the surgical technique groups. Preoperative imaging assessed tooth position and root morphology. Intraoperative variables an... Piezo surgery, 3D imaging, and navigation-guided extraction techniques demonstrated a shorter mean duration of surgery and lower incidence of intraoperative complications compared to traditional extra... Advanced imaging-guided techniques, particularly 3D imaging and navigation-guided extraction, offer significant benefits for patients undergoing wisdom tooth extraction by improving surgical precision...

Bibliometric analysis on physical ergonomics: A visual mapping approach.

The concept of ergonomics in health services is attracting significant attention in the scientific community. There is a need for an integrated study presenting a summary of the published literature b... The aim of this study is to provide a summary of the published literature supported by detailed bibliometric properties.... Within the scope of this study, a total of 3008 articles on ergonomics in the health field were reviewed and analyzed using a bibliometric method.... It reveals the trends of the publications conducted between 1999-2023, and defines the common citation structure between the articles, bibliographic coupling, and keyword co-occurrences. This study pr... The research results provide comprehensive information to the relevant literature, and define global research focuses and future scopes. This serves as a guide for academics to understand developments...

Cashing in: cost-benefit analysis framework for digital hospitals.

For many countries, especially those outside the USA without incentive payments, implementing and maintaining electronic medical records (EMR) is expensive and can be controversial given the large amo... This paper outlines the development of an evidence-based digital health cost-benefit analysis (eHealth-CBA) framework to calculate the total economic value of the EMR implementation over time. A net p... We developed a three-stage process that takes into account the complexity of the healthcare system and its stakeholders, the investment appraisal and evaluation practice, and the existing knowledge of... The proposed framework is the first step toward developing a comprehensive evaluation framework for EMRs to inform health decision-makers about the economic value of digital investments rather than ju...

Survival analysis and associated factors of highgrade glioma patients.

High-grade gliomas are the most common primary brain tumors in adults, and they usually have a quick fatal course. Average survival is 18 months, mainly, because of tumor resistance to Stupp protocol.... To determine high-grade glioma patient survival and the effect of persuasion variables on survival.... We conducted a longitudinal descriptive study in which 80 untreated recently diagnosed high-grade glioma patients participated. A survey was conducted regarding their exposure to some risk factors, de... Eighty patients' clinical, demographic and lifestyle characteristics were analyzed, as well as their survival rates and the average survival time is 784 days (interquartile range: 928). Factors like a... We determined that only three of the analyzed variables have an important effect on survival time when it comes to high-grade glioma patients....

Functional substrate analysis in patients with persistent atrial fibrillation.

The aim of this study was to describe the correlation between atrial electrogram duration map (AEDUM), spatiotemporal electrogram dispersion (STED) and low voltage areas (LVA) in patients with persist... The degree of left atrial (LA) tissue remodelling and augmented anisotropic conduction is one of the major issues related to PsAF ablation outcome.... This study enrolled consecutive patients with PsAF undergoing pulmonary vein isolation. In all patients, voltage, AEDUM and STED maps were created, and the correlation was reported between these three... A total of 40 patients with PsAF were enrolled. The mean age was 62.2 ± 7.4 years, and males were 72.5% (n = 29). The overall bipolar voltage of the LA was 3.06 ± 1.87 mV. All patients had at least on... AEDUM and STED maps allow to identify areas of conductive dysfunction as a possible atrial substrate even if a normal voltage is detected....